Robert R. Bies, PharmD, PhD
Adjunct Professor of Medicine
Bio
Dr. Bies is currently Associate Professor of Pharmaceutical Sciences at the School of Pharmacy and Pharmaceutical Sciences as well as a member of the Computational Data Sciences and Engineering Program at the State University of New York at Buffalo. Prior to this, Dr. Bies was Associate Professor of Medicine and Medical and Molecular Genetics at the Indiana University School of Medicine and Director of the Disease and Therapeutic Response Modeling program for the Indiana Clinical Translational Sciences Institute. He serves as: collaborating scientist at CAMH, University of Toronto; Adjunct Associate Professor of Pharmacology and Therapeutics, Roswell Park Cancer Institute, North American and executive editor for the British Journal of Clinical Pharmacology; and on the editorial boards of the Journal of Pharmacokinetics and Pharmacodynamics, Clinical Pharmacology and Therapeutics:Pharmacometrics and Systems Pharmacology and Biopharmaceutics and Drug Disposition. Dr. Bies is a member of AAPS, ISoP, ACCP and ASCPT.
Dr. Bies received: a BSc degree in Pharmacy from the University of Toronto (1991); a Pharm.D. from the UTHSCSA and the University of Texas at Austin (1994); and a Ph.D. Pharmacology from Georgetown University in 1998. This was followed by postdoctoral training at the Center for Drug Development Sciences until 2000.
His research focuses on the application of pharmacometric approaches in psychiatry, oncology, neurology and cardiovascular disease and novel methods development including machine learning approaches to predictive model development, model selection and optimization methods for parameter optimization in dynamic systems.
Year | Degree | Institution |
---|---|---|
1998 | PhD | Georgetown University |
1994 | PharmD | University of Texas |
1991 | BSC | University of Toronto |
Yang QJ; Jerath A; Bies RR; Wasowicz M; Pang KS; Biopharmaceutics & drug disposition 2015 Feb 22
Tsuboi T; Suzuki T; Bies RR; Remington G; Pollock BG; Mimura M; Uchida H; Schizophrenia research 2015 Apr 9
Vélez de Mendizábal N; Strother RM; Farag SS; Broxmeyer HE; Messina-Graham S; Chitnis SD; Bies RR; Clinical pharmacokinetics 2014 Mar
Yoshida K; Bies RR; Suzuki T; Remington G; Pollock BG; Mizuno Y; Mimura M; Uchida H; Schizophrenia research 2014 Feb 1
Li CH; Sherer EA; Lewis LD; Bies RR; Journal of clinical pharmacology 2014 Dec 16
Vélez de Mendizábal N; Jones DR; Jahn A; Bies RR; Brown JW; Clinical pharmacokinetics 2014 Dec 12
Li CH; Stratford RE Jr; Velez de Mendizabal N; Cremers TI; Pollock BG; Mulsant BH; Remington G; Bies RR; Journal of translational medicine 2014 Aug 20
Velez de Mendizabal N; Hutmacher MM; Troconiz IF; Goñi J; Villoslada P; Bagnato F; Bies RR; PloS one 2013 Sep 5
Empey PE; de Mendizabal NV; Bell MJ; Bies RR; Anderson KB; Kochanek PM; Adelson PD; Poloyac SM; Pediatric TBI Consortium: Hypothermia Investigators; Critical care medicine 2013 Oct
Stevens J; Bies RR; Shekhar A; Anand A; British journal of clinical pharmacology 2013 Mar
Li CH; Pollock BG; Lyketsos CG; Vaidya V; Drye LT; Kirshner M; Sorisio D; Bies RR; DIADS-2 Research Group; Journal of clinical pharmacology 2013 Jan 24
Sherer EA; Bies RR; Clancy P; Norman PE; Golledge J; CPT: pharmacometrics & systems pharmacology 2012 Oct 24
Wessels AM; Jin Y; Pollock BG; Frank E; Lange AC; Vrijens B; Fagiolini A; Kupfer DJ; Rucci P; Kepple G; Anderton J; Buttenfield J; Bies RR; International clinical psychopharmacology 2012 Nov
Aregbe AO; Sherer EA; Egorin MJ; Scher HI; Solit DB; Ramanathan RK; Ramalingam S; Belani CP; Ivy PS; Bies RR; Cancer chemotherapy and pharmacology 2012 Mar 27
Sherer EA; Sale ME; Pollock BG; Belani CP; Egorin MJ; Ivy PS; Lieberman JA; Manuck SB; Marder SR; Muldoon MF; Scher HI; Solit DB; Bies RR; Journal of pharmacokinetics and pharmacodynamics 2012 Jul 6
Wessels AM; Bies RR; Pollock BG; Schneider LS; Lieberman JA; Stroup S; Li CH; Coley K; Kirshner MM; Marder SR; Journal of clinical pharmacology 2011 Jan 5